1. "Adult Leukemia"
  2. "Dermatology"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (10)
  3. Research Letter (2)
  4. Book Section (1)
  5. Review (1)
Groups
  1. Adult Leukemia (32)
  2. Center for Hematologic Malignancies (32)
  3. Department of Medicine (32)
  4. Dermatology (32)
  5. Dermatology Service (32)
  6. Division of Subspecialty Medicine (32)

More Groups

People
  1. Mario Lacouture (21)
  2. Omar Abdel-Wahab (14)
  3. Eli Diamond (12)
  4. Raajit Rampal (12)
  5. Benjamin Durham (10)
  6. Ahmet Dogan (8)

More People

Years
  1. 2023 (6)
  2. 2022 (5)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Blood (11)
  2. Journal of Clinical Oncology (3)
  3. Pediatric Blood and Cancer (3)
  4. British Journal of Haematology (2)
  5. Cancer Discovery (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. John Wiley & Sons (4)
  3. American Society of Clinical Oncology (3)
  4. Wiley Periodicals, Inc (3)
  5. American Association for Cancer Research (2)
  6. Elsevier Ltd (1)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes with single-agent BRAF-inhibitor therapy in Erdheim-Chester disease
    Meeting Abstract

    Goyal, G.; Reiner, A.; Bossert, D.; Sigler, A.; Buthorn, J.; Lacouture, M.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Meeting Abstract

    Parisi, R.; Cowen, E. A.; Gu, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia
    Journal Article

    Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
    Review

    Nocco, S.; Andriano, T. M.; Bose, A.; Chilov, M.; Godwin, K.; Dranitsaris, G.; Wu, S.; Lacouture, M. E.; Roeker, L. E.; Mato, A. R.; more...
    Critical Reviews in Oncology/Hematology (2022)

    Fulltext@MSK | Save